Full View

Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF

PS Jhund, SD Solomon, KF Docherty, HJL Heerspink… - Circulation, 2021 - Am Heart Assoc
Background: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …
被引用次数：277 相关文章

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF

PS Jhund, SD Solomon, KF Docherty… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …

Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF

PS Jhund, SD Solomon, KF Docherty, HJL Heerspink… - Circulation, 2021 - eprints.gla.ac.uk
Background: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease (CKD) which complicates pharmacological management and is …
[PDF] dapatrial.org

[PDF][PDF] Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

PS Jhund, JJV McMurray - Circulation, 2021 - dapatrial.org
BACKGROUND: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF

PS Jhund, SD Solomon, KF Docherty… - …, 2021 - research.regionh.dk
BACKGROUND: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

PS Jhund, JJV McMurray - Circulation, 2021 - Am Heart Assoc
BACKGROUND: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …
[HTML] nih.gov

[HTML][HTML] Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF

PS Jhund, SD Solomon, KF Docherty, HJL Heerspink… - Circulation, 2021 - ncbi.nlm.nih.gov
BACKGROUND: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF

PS Jhund, SD Solomon, KF Docherty, HJL Heerspink… - Circulation, 2021 - research.rug.nl
Background: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease (CKD) which complicates pharmacological management and is …

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF

PS Jhund, KF Docherty, JJV McMurray, SD Solomon… - Circulation, 2021 - elibrary.ru
Background: Many patients with heart failure and reduced ejection fraction (HFrEF) have
chronic kidney disease that complicates pharmacological management and is associated …

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

PS Jhund, SD Solomon, KF Docherty, HJL Heerspink… - Circulation, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Many patients with heart failure
and reduced ejection fraction (HFrEF) have chronic kidney disease that complicates …